Follow
Michelle Chonwerawong
Michelle Chonwerawong
Postdoctoral Scientist, Hudson Institute of Medical Research
Verified email at hudson.org.au - Homepage
Title
Cited by
Cited by
Year
Regulation and functions of inflammasome-mediated cytokines in Helicobacter pylori infection
M Chonwerawong, RL Ferrero
Microbes and infection 19 (9-10), 449-458, 2017
242017
Mouse models of Helicobacter infection and gastric pathologies
K D'Costa, M Chonwerawong, RL Ferrero
JoVE (Journal of Visualized Experiments), e56985, 2018
142018
Innate immune molecule NLRC5 protects mice from Helicobacter-induced formation of gastric lymphoid tissue
M Chonwerawong, J Ferrand, HM Chaudhry, C Higgins, MM Walker, ...
Gastroenterology 159 (1), 169-182. e8, 2020
132020
The microbiome and host mucosal interactions in urinary tract diseases
B Jones-Freeman, M Chonwerawong, VR Marcelino, AV Deshpande, ...
Mucosal Immunology 14 (4), 779-792, 2021
112021
Key Technologies for Progressing Discovery of Microbiome-Based Medicines
RB Young, VR Marcelino, M Chonwerawong, EL Gulliver, SC Forster
Frontiers in Microbiology 12, 1604, 2021
52021
Interferon-γ promotes gastric lymphoid follicle formation but not gastritis in Helicobacter-infected BALB/c mice
M Chonwerawong, P Avé, M Huerre, RL Ferrero
Gut pathogens 8 (1), 1-9, 2016
52016
Analysis of Innate Immune Responses to Helicobacter pylori
M Chonwerawong, RL Ferrero
Helicobacter Pylori, 191-214, 2021
12021
Toll-like receptor 9 promotes initiation of gastric tumorigenesis by augmenting inflammation and cellular proliferation
K Tang, L McLeod, T Livis, AC West, R Dawson, L Yu, JJ Balic, ...
Cellular and Molecular Gastroenterology and Hepatology, 2022
2022
the future of microbiome‐based therapeutics
EL Gulliver, RB Young, M Chonwerawong, GL D'Adamo, T Thomason, ...
Alimentary Pharmacology & Therapeutics, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–9